Soaring prices for everything from cancer treatments to hepatitis C pills that cost more than $100,000 have sparked outcry in the United States in recent years, but calls for change have gone largely unheeded.
Sep 23, 2015
0
34
In a guideline issued by the American Cancer Society and published in the May/June issue of CA: A Cancer Journal for Clinicians, recommendations are presented regarding diet and exercise for reducing the risk for recurrence ...
Aug 26, 2022
0
4
Loyola University Hospital spine surgeon Dr. Alexander Ghanayem is co-author of a landmark editorial challenging the integrity of published industry-sponsored research involving a bone-growth product.
Jun 28, 2011
0
0
A new study led by scientists at the University of Birmingham has shed fresh light on how a key front-line drug kills the tuberculosis bacterium.
Apr 23, 2020
0
110
Pre-COVID-19 psychotropic medication use is associated with higher risk for incident dementia following hospitalization for COVID-19 (post-COVID dementia) in older adults, according to a study published online March 18 in ...
Mar 25, 2022
0
17
Critics of the pharmaceutical industry say it is misaligned with public interest. So is it time to nationalise the sector? Experts debate the issue in The BMJ today.
Mar 4, 2020
1
161
The risk and 12-month burden of incident diabetes is increased for individuals in the postacute phase of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, according to a study published online March ...
Mar 30, 2022
0
12
Donald Trump's administration unveiled a plan Wednesday to allow imports of lower-priced prescription drugs from Canada and other countries, but it was opposed by Ottawa, which said the scheme threatened its own medicine ...
Dec 19, 2019
0
1
(HealthDay)—The 2021 U.S. Preventive Services Task Force (USPSTF) criteria for lung cancer screening increase eligibility compared with earlier screening criteria, with reduced racial disparity, according to a study published ...
Jan 19, 2022
0
2
Medical students in the United States are frequently exposed to pharmaceutical marketing, even in their preclinical years, and the extent of their contact with industry is associated with positive attitudes about marketing ...
May 24, 2011
0
0
